1. Sylla BS, Wild CP. A million africans a year dying from
cancer by 2030: what can cancer research and control offer to the continent?
International journal of cancer. 2012 Jan 15;130(2):245-50.
2. Lunenfeld B, Stratton P. The clinical consequences of an
ageing world and preventive strategies. Best practice & research Clinical
obstetrics & gynaecology. 2013 Oct 1;27(5):643-59.
3. Shams M, Abdallah S, Alsadoun L, Hamid YH, Gasim R, Hassan A.
Oncological horizons: The synergy of medical and surgical innovations in cancer
treatment. Cureus. 2023 Nov 22;15(11):e49249.
4. Vasan N, Baselga J, Hyman DM. A view on drug resistance in
cancer. Nature. 2019 Nov 14;575(7782):299-309.
5. Baldo BA, Pham NH. Adverse reactions to targeted and
non-targeted chemotherapeutic drugs with emphasis on hypersensitivity responses
and the invasive metastatic switch. Cancer and Metastasis Reviews. 2013
Dec;32(3):723-61.
6. Roberts DM, Buckley NA. Pharmacokinetic considerations in
clinical toxicology: clinical applications. Clinical pharmacokinetics. 2007
Nov;46(11):897-939.
7. Kazdin AE. Evidence-based treatment research: Advances,
limitations, and next steps. American Psychologist. 2011 Nov;66(8):685.
8. Chakraborty T, Saini V, Govila D and
Singh G “Four most life threatening urogenital cancer and its management”
International Journal of Pharmaceutical Sciences and Research, 2018, 9(8):
3166-3174.
9. Dewhirst MW, Secomb TW. Transport of drugs from blood vessels
to tumour tissue. Nature Reviews Cancer. 2017 Dec;17(12):738-50.
10. Heffernan AJ, Sime FB, Lipman J, Roberts JA. Individualising
therapy to minimize bacterial multidrug resistance. Drugs. 2018
Apr;78(6):621-41.
11. Avner BS, Fialho AM, Chakrabarty AM. Overcoming drug
resistance in multi-drug resistant cancers and microorganisms: a conceptual
framework. Bioengineered. 2012 Sep 18;3(5):262-70.
12. Senapati S, Mahanta AK, Kumar S, Maiti P. Controlled drug
delivery vehicles for cancer treatment and their performance. Signal
transduction and targeted therapy. 2018 Mar 16;3(1):7.
13. Mallick MA, Chakraborty T et.al “Schematic diagrammatic
preparation methods of polymeric nanoparticles for biomedical applications in
recent and future prospects” European Chemical Bulletin , 2023,12(10):1721-1733
14. Khan T, Qureshi ZN, Niazi A, Ejaz M, Khan K. Biomarkers
emerging in nanotheranostics and precision medicine. InNanotheranostics and
Precision Oncology 2026 Jan 1 (pp. 609-634). Academic Press.
15. Sandbhor P, Palkar P, Bhat S, John G, Goda JS. Nanomedicine
as a multimodal therapeutic paradigm against cancer: on the way forward in
advancing precision therapy. Nanoscale. 2024;16(13):6330-64.
16. Edis Z, Wang J, Waqas MK, Ijaz M, Ijaz M.
Nanocarriers-mediated drug delivery systems for anticancer agents: an overview
and perspectives. International journal of nanomedicine. 2021 Feb 17:1313-30.
17. Coccia M, Finardi U. Emerging nanotechnological research for
future pathways of biomedicine. International Journal of Biomedical nanoscience
and nanotechnology. 2012 Jan 1;2(3-4):299-317.
18. Wu T, Dai Y. Tumor microenvironment and therapeutic response.
Cancer letters. 2017 Feb 28;387:61-8.
19. Huang Q, Tong F, Chen J, Kayumov M, Lv Y, Shi Y, Ye B, Gao H.
Tumor Microenvironment‐Responsive Nanomedicines for Potentiating Cancer
Immunotherapy. Advanced Science. 2025:e13567.
20. Chakraborty T, Saini V, Singh G ,
Govila D and Pandurangan A “Causes and Management of Major Microbial Infections
in Upper Sensory Organs of the Body” International Journal of Pharmaceutical
Sciences Review and Research, 2018, 48(1):43-51.
21. Alonso MJ. Nanomedicines for overcoming biological barriers.
Biomedicine & Pharmacotherapy. 2004 Apr 1;58(3):168-72.
22. Engin AB, Nikitovic D, Neagu M, Henrich-Noack P, Docea AO,
Shtilman MI, Golokhvast K, Tsatsakis AM. Mechanistic understanding of
nanoparticles’ interactions with extracellular matrix: the cell and immune
system. Particle and fibre toxicology. 2017 Jun 24;14(1):22.
23. Subhan MA, Yalamarty SS, Filipczak N, Parveen F, Torchilin
VP. Recent advances in tumor targeting via EPR effect for cancer treatment.
Journal of personalized medicine. 2021 Jun 18;11(6):571.
24. Sharifi M, Cho WC, Ansariesfahani A, Tarharoudi R,
Malekisarvar H, Sari S, Bloukh SH, Edis Z, Amin M, Gleghorn JP, Hagen TL. An
updated review on EPR-based solid tumor targeting nanocarriers for cancer
treatment. Cancers. 2022 Jun 10;14(12):2868.
25. Srinivasarao M, Galliford CV, Low PS. Principles in the
design of ligand-targeted cancer therapeutics and imaging agents. Nature
reviews Drug discovery. 2015 Mar;14(3):203-19.
26. Chakraborty T, Saini V, Narwal P,
Gupta S “Formulation and evaluation of both stomach and Intestine drug delivery
system from unit solid dosage tablet formulation” World Journal of
Pharmaceutical Research, 2015:4(10): 1377-1392.
27. Desai N, Rana D, Salave S, Benival D, Khunt D, Prajapati BG.
Achieving endo/lysosomal escape using smart nanosystems for efficient cellular
delivery. Molecules. 2024 Jul 1;29(13):3131.
28. Varkouhi AK, Scholte M, Storm G, Haisma HJ. Endosomal escape
pathways for delivery of biologicals. Journal of Controlled Release. 2011 May
10;151(3):220-8.
29. Sen S, Xavier J, Kumar N, Ahmad MZ, Ranjan OP. Exosomes as
natural nanocarrier-based drug delivery system: recent insights and future
perspectives. 3 Biotech. 2023 Mar;13(3):101.
30. Gangadaran P, Madhyastha H, Madhyastha R, Rajendran RL,
Nakajima Y, Watanabe N, Velikkakath AK, Hong CM, Gopi RV, Muthukalianan GK,
Valsala Gopalakrishnan A. The emerging role of exosomes in innate immunity,
diagnosis and therapy. Frontiers in Immunology. 2023 Jan 16;13:1085057.
31. Seidi F, Jenjob R, Crespy D. Designing smart polymer
conjugates for controlled release of payloads. Chemical reviews. 2018 Mar
13;118(7):3965-4036.
32. Chakraborty T, Gupta S, Saini V. In
vivo Study of Insulin-loaded Microemulsion Topical gel with Aloe vera for the
Treatment of Dermatologic Manifestation of Diabetes. Research J. Pharm. and
Tech. 2020;13(9):4115-4124
33. Pucci C, Degl'Innocenti A, Gümüş MB, Ciofani G.
Superparamagnetic iron oxide nanoparticles for magnetic hyperthermia: Recent
advancements, molecular effects, and future directions in the omics era.
Biomaterials Science. 2022;10(9):2103-21.
34. Xue VW, Wong SC, Song G, Cho WC. Promising RNA-based cancer
gene therapy using extracellular vesicles for drug delivery. Expert Opinion on
Biological Therapy. 2020 Jul 2;20(7):767-77.
35. Caldorera-Moore ME, Liechty WB, Peppas NA. Responsive
theranostic systems: integration of diagnostic imaging agents and responsive
controlled release drug delivery carriers. Accounts of chemical research. 2011
Oct 18;44(10):1061-70.
36. Guo F, Du Y, Wang Y, Wang M, Wang L, Yu N, Luo S, Wu F, Yang
G. Targeted drug delivery systems for matrix metalloproteinase-responsive a
noparticles in tumor cells: a review. International Journal of Biological
Macromolecules. 2024 Feb 1;257:128658
37. Saini P, Chakraborty T, Jain A,
Chaudhary J, Saini V “Comparative Study of Resins in the Formulation of Taste
Masked Suspension of Erythromycin” Int. J.Pharm. Sci. Rev. Res.,2013, 22(1): 257-263
38. Raza A, Rasheed T, Nabeel F, Hayat U, Bilal M, Iqbal HM.
Endogenous and exogenous stimuli-responsive drug delivery systems for
programmed site-specific release. Molecules. 2019 Mar 21;24(6):1117.
39. Jones SJ, Taylor AF, Beales PA. Towards feedback-controlled
nanomedicines for smart, adaptive delivery. Experimental Biology and Medicine.
2019 Mar;244(4):283-93.
40. Sharma A, Chakraborty T, Gupta S,
Sharma A, Pahari PK, Biomarkers: An Important Tool for Diagnosing and Treating
Breast Cancer, Journal of Pharmaceutical Research International, 2020, 32(12):
46-54.
41. Wahane A, Waghmode A, Kapphahn A, Dhuri K, Gupta A, Bahal R.
Role of lipid-based and polymer-based non-viral vectors in nucleic acid
delivery for next-generation gene therapy. Molecules. 2020 Jun 22;25(12):2866.
42. Perrigue PM, Murray RA, Mielcarek A, Henschke A, Moya SE.
Degradation of drug delivery nanocarriers and payload release: A review of
physical methods for tracing nanocarrier biological fate. Pharmaceutics. 2021
May 21;13(6):770.
43. Dennis JM. Precision medicine in type 2 diabetes: using
individualized prediction models to optimize selection of treatment. Diabetes.
2020 Oct 1;69(10):2075-85.
44. Mehta P, Shende P. Evasion of opsonization of macromolecules
using novel surface‐modification and biological‐camouflage‐mediated techniques
for next‐generation drug delivery. Cell Biochemistry and Function. 2023
Dec;41(8):1031-43.
45. Chakraborty T, Natasha, Saini V,
Ruby “Formulation and evaluation of controlled release floating tablets of
cefixime using hydrophilic polymers” International Research Journal of
Pharmacy, 2019, 10 (1): 171-175.
46. Kabir M, Rana MR, Debnath A. The Role of Quality Assurance in
Accelerating Pharmaceutical Research and Development: Strategies for Ensuring
Regulatory Compliance and Product Integrity. Integrative Biomedical Research.
2024 Dec 8;8(12):1-1.
47. Sharma M, Grover M, Suryavanshi SJ, Sharma N, Shukla VK.
Comparative Review of Clinical Trial Regulations in Different Countries: Current
Scenario and Future Prospect. Reviews on Recent Clinical Trials. 2025.
48. Von Braun J, Brown MA. Ethical questions of equitable
worldwide food production systems. Plant physiology. 2003 Nov 1;133(3):1040-5.
49. Li C, Ma L, Xue Z, Li X, Zhu S, Wang T. Pushing the
Frontiers: Artificial Intelligence (AI)‐Guided Programmable Concepts in Binary
Self‐Assembly of Colloidal Nanoparticles. Advanced Science. 2025 Apr
26:2501000.
50. Das KP. Nanoparticles and convergence of artificial
intelligence for targeted drug delivery for cancer therapy: Current progress
and challenges. Frontiers in Medical Technology. 2023 Jan 6;4:1067144 .
51. Bawa S, Yasmin S, Saini V,
Chakraborty T, Chaudhaery SS, Ansari MY, “Treatment and Management of
Hypertension by Targeting ACE Inhibitors: in silico Approach” International
Journal of Bioautomation, 2019, 23(1): 13-28.
52. Ciardiello F, Arnold D, Casali PG, Cervantes A, Douillard JY,
Eggermont A, Eniu A, McGregor K, Peters S, Piccart M, Popescu R. Delivering
precision medicine in oncology today and in future—the promise and challenges
of personalised cancer medicine: a position paper by the European Society for
Medical Oncology (ESMO). Annals of Oncology. 2014 Sep 1;25(9):1673-8.
53. Edis Z, Wang J, Waqas MK, Ijaz M, Ijaz M.
Nanocarriers-mediated drug delivery systems for anticancer agents: an overview
and perspectives. International journal of nanomedicine. 2021 Feb 17:1313-30.
54. Abdellatif AA, Mohammed HA, Khan RA, Singh V, Bouazzaoui A,
Yusuf M, Akhtar N, Khan M, Al-Subaiyel A, Mohammed SA, Al-Omar MS. Nano-scale
delivery: A comprehensive review of nano-structured devices, preparative
techniques, site-specificity designs, biomedical applications, commercial
products, and references to safety, cellular uptake, and organ toxicity.
Nanotechnology Reviews. 2021 Oct 21;10(1):1493-559.
55. Chakraborty T, Saini V, Sharma S,
Kaur B, Dhingra G “Antifungal gel; for different routes of administration and
different drug delivery system” International Journal of Biopharmaceutics,
2014, 5(3): 230-240
56. Zhou L, Li K, Liu Y, Zhang R, Yao Y, Chen Q, Xie D, Zhang X.
Living cell‐derived intelligent nanobots for precision oncotherapy. Advanced
Functional Materials. 2024 Mar;34(10):2311857.
57. Wu Q, Yao X, Duan X, Chen X, Zhang J. Nanomedicine
Reimagined: Translational Strategies for Precision Tumor Theranostics. Advanced
Materials. 2025 Sep 6:e10293.
58. Wen F, Wang L, Li X, Zhao J, Xu T, Zhu J, Ma L, Wang X.
Precision Nanomedicine for Cancer: Innovations, Strategies, and Translational
Challenges. OncoTargets and Therapy. 2025 Dec 31:1125-48.